Protein Signatures and Tissue Diagnosis of Pancreatic Cancer
Endoscopic ultrasound-guided fine needle aspiration (EUS-guided FNA) fails to diagnose up to 25% of patients with pancreatic ductal adenocarcinoma (PDAC). Proteomics may help to overcome this clinical dilemma. We hypothesized that soluble protein signatures can differentiate PDAC from benign tissues.
Source: Journal of the American College of Surgeons - Category: Surgery Authors: Patrick W. Underwood, Michael H. Gerber, Kathy Nguyen, Daniel Delitto, Song Han, Ryan M. Thomas, Christopher E. Forsmark, Jose G. Trevino, William E. Gooding, Steven J. Hughes Tags: Original Scientific Article Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Fine Needle Aspiration | Pancreas | Pancreatic Cancer | Surgery | Ultrasound